Corporate Social Responsibility Press Release
provided by 
12.04.2008 - 08:00am ET
News from:
Novartis International AG
Novartis Awards Program Continues to Drive Energy Savings and Environmental Progress
(CSRwire) - 2008 Novartis Energy Excellence Awards recognize four projects
from Austria, Germany, Indonesia and Switzerland
- Now in its fifth year, the award is integral to the company's
commitment to conserve energy and reduce emissions
- The 46 entries for the 2008 awards have already achieved substantial
energy savings and greenhouse-gas (GHG) emissions
reductions
BASEL. - December, 4, 2008 – Novartis has announced
the winners of its 2008 Energy Excellence Awards, a global program that
recognizes the efforts from associates to improving the company's energy
efficiency and reducing GHG emissions.
"Our plan to reduce energy use and GHG emissions includes ambitious
targets in line with the Kyoto Protocol – that is to reduce emissions by
at least 5 percent below the 1990 level by 2012," explains Thomas Wellauer,
Head of Corporate Affairs and a member of the Executive Committee of
Novartis. "The Energy Excellence Awards are very effective in mobilizing
our associates' creativity to contribute to this global effort. This is an
integral part in our drive to reduce our carbon footprint as a company –
these initiatives help accelerate our efforts and these efforts are
showing a genuine impact."
This year's four winning projects were from Austria, Germany, Indonesia
and Switzerland. They were selected from a total of 46 entries submitted
by Novartis sites across the world. The judging panel was composed of six
international specialists from Non-governmental Organizations, academia
and business organizations, together with three Novartis experts. Key
selection criteria included supporting business growth while reducing C02
emissions, minimizing energy costs and maximizing the use of renewable
energy.
The four winning projects of the 2008 Novartis Energy Excellence Awards
are:
Sandoz Kundl – Continued optimization of the penicillin and
cephalosporin processes
The Sandoz Division in Kundl, Austria, is the group's largest
manufacturing site worldwide. Its innovative approach to using synthetic
media and optimizing the carbon source utilization – which was
implemented for penicillin two years ago – has now been extended to
cephalosporin, the second key strain of fermentation products.
Optimization of both penicillin and cephalosporin processes have led to
additional major savings, mainly with regards to aeration, but also
agitation. The project showed a payback of about one year on an investment
of USD 3.3 m. Meanwhile, electricity savings and respective Scope 2 GHG
emissions were reduced by 26%, amounting to 9% of absolute annual savings
for the entire Kundl facility.
Novartis Pharma Wehr – Maximizing the use of renewable energy
By using the locally available wood chips as the major fuel source, the
production facility of Novartis Pharma in Wehr, Germany, managed to switch
the site's energy consumption to primarily renewable sources, thus helping
to increase the use of renewable energy from biomass by 50% for the entire
Novartis group. In addition to ensuring more stable energy prices in the
future, this change has contributed to reducing the site's annual Scope 1
GHG emissions by about two third. This represents circa 0.8% of all Scope
1 GHG emissions at Novartis.
CibaVision Indonesia – Energy efficiency to minimize energy
consumption
A comprehensive energy efficiency project at the Consumer Health Division
(Ciba Vision) in Batam, Indonesia, comprises a variety of elements to
minimize its energy consumption. These include boiler use, compressed air,
chilling and lighting, production synchronization and employee behavior.
The project has an excellent payback on investment within a few months.
The savings achieved amount to five percent of on-site and 11 percent of
purchased energy use for the entire facility.
Novartis HQ Basel – Becoming energy efficient through employee
education
At Novartis headquarters in Basel, Switzerland, a comprehensive approach
to managing energy and climate is being implemented as a model for other
sites to follow. The program focuses on energy management and incorporates
extensive training and awareness-building activities to change the behavior
of associates. Two Site Energy Committees operating on both technical and
management levels are overseeing the program and ensuring targets are met.
For instance, energy efficiency targets have been assigned to individual
buildings and agreed with the local authorities for new buildings.
In addition, Novartis applies a proactive policy for capital investment
associated with energy conservation. Energy efficiency and renewable
energy challenges have become mandatory elements of the capital
appropriation procedures for all major projects worldwide.
About
Novartis AG provides healthcare solutions that address the evolving needs
of patients and societies. Focused solely on healthcare, Novartis offers a
diversified portfolio to best meet these needs: innovative medicines,
cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools
and consumer health products. Novartis is the only company with leading
positions in these areas. In 2007, the Group's continuing operations
(excluding divestments in 2007) achieved net sales of USD 38.1 billion and
net income of USD 6.5 billion. Approximately USD 6.4 billion was invested
in R&D activities throughout the Group. Headquartered in Basel,
Switzerland, Novartis Group companies employ approximately 97,000
full-time associates and operate in over 140 countries around the world.
For more information, please visit http://www.novartis.com.
For more information please contact:
Christine Elleboode-Zwaans, Global Media Relations Novartis +41 61 324 3348 +41 79 828 4718
Central Media Line +41 61 324 2200
www.novartis.com
News Categories:
Ratings & Awards and Environment
More Novartis International AG news on CSRwire,
click here.
|